Citadel Advisors’s Nexalin Technology Inc Warrant NXLIW Stock Holding History

Citadel Advisors’s Portfolio NXLIW Stock Details NXLIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-90,907	Closed	-$7.27K	–	13703
2025 Q2	$7.27K	Sell	90,907 -2,226	-2%	-$286	﹤0.01%	12215
2025 Q1	$16.4K	Sell	93,133 -28,142	-23%	-$7.51K	﹤0.01%	13281
2024 Q4	$44.6K	Sell	121,275 -28,357	-19%	-$10.3K	﹤0.01%	12504
2024 Q3	$15K	Buy	149,632 +1,224	+0.8%	+$206	﹤0.01%	12995
2024 Q2	$59.4K	Sell	148,408 -10,757	-7%	-$2.33K	﹤0.01%	11573
2024 Q1	$6.65K	Buy	159,165 +142,952	+882%	+$3.65K	﹤0.01%	13653
2023 Q4	$126	Buy	16,213 +623	+4%	+$9	﹤0.01%	14121
2023 Q3	$390	Buy	15,590 +875	+6%	+$50	﹤0.01%	14069
2023 Q2	$1.45K	Sell	14,715 -857	-6%	-$107	﹤0.01%	13935
2023 Q1	$1.48K	Buy	15,572 +4,372	+39%	+$588	﹤0.01%	14293
2022 Q4	$2.24K	Buy	+11,200	New	+$2.02K	﹤0.01%	14361

Citadel Advisors's NXLIW Position: Q3 2025 in Review

Citadel Advisors sold out of Nexalin Technology Inc Warrant (NXLIW) in Q3 2025, closing a stake of 90,907 shares — an estimated $7.27K sold.

Citadel Advisors first reported a position in NXLIW in Q4 2022 and held it in 11 quarters. The position peaked at $59.4K in Q2 2024. 0 funds tracked by Wall St. Rank hold NXLIW as of Q3 2025.

Citadel Advisors reported no remaining Nexalin Technology Inc Warrant position as of Q3 2025 after selling out during the quarter.
Citadel Advisors sold 90,907 Nexalin Technology Inc Warrant shares in Q3 2025, an estimated $7.27K.
Citadel Advisors first reported a position in Nexalin Technology Inc Warrant in Q4 2022 and held it in 11 quarters.
Citadel Advisors's Nexalin Technology Inc Warrant position peaked at $59.4K in Q2 2024.
0 funds tracked by Wall St. Rank held Nexalin Technology Inc Warrant as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.